Figure 1.
Effects of microbiota modification through population depletion with antibiotics on blood pressure, proteinuria, morphology, and disease activity in the imiquimod (IMQ) group. (A) Systolic blood pressure (SBP) assessed with tail-cuff plethysmography, (B) proteinuria, (C) organ hypertrophy levels, (D) circulating double-stranded DNA (anti-ds-DNA) and anti-cardiolipin autoantibodies, and interferon (IFN)α levels in control (CTR), IMQ and IMQ-groups treated with Vancomycin (VANCO) or a cocktail of antibiotics (MIX). The data is represented as means ± SEM. The evolution of tail SBP was analysed by two-way ANOVA with the Tukey’s multiple comparison test. The rest of the variables were tested with one-way ANOVA and Tukey post hoc test (morphological variables, and plasma anti-ds-DNA), or Kruskal–Wallis with Dunn’s multiple comparison (proteinuria, anti-cardiolipin, plasma IFNα). * p < 0.05, † p < 0.01, ‡ p < 0.001 in comparison with CTR; * p < 0.05, † p < 0.01, ‡ p < 0.001 in comparison with IMQ.